Methods/design
Headache, neck tightness, pain, bone tumor, ICHD-3, claustrophobia, trauma
HEADACHE DISORDERS, DISORDERS, BONE TUBERCULOSIS, BONE TUMOR, CERVICAL SPINE DYSFUNCTION, DISEASES, OSTEOPOROSIS
This study used a fully randomized, controlled, double-blinded, double-si-mulation research method. The study was in accordance with the Consolidated Standards of Reporting Trials (CONSORT) checklist guidelines. The study was registered in the China Clinical Trial Registration Center (Registration Number: ChiCTR2100054072 23/08/2021) and reviewed and approved by the Ethics Committee of the first affiliated hospital of Zhejiang Chinese Medical University with approval number (Ethics Number: 2021-K-491–01 19/07/2021). All subjects signed an informed consent before the study. All methods were carried out in accordance with the tenets of the Declaration of Helsinki as well as the relevant guidelines and regulations.Eligibility criteria: All participants were diagnosed with CEH according to the diagnostic criteria for CEH in the third edition of the International Classification of Headache Disorders (ICHD-3) in 2018. They were examined at the outpatient clinic of the first affiliated hospital of Zhejiang Chinese Medical University from January 2022 to December 2022.Inclusion criteria were as follows: CEH pain intensity 3–8 on 10-point pain scale; Cervical spine dysfunction; Cervical motion reduction; Headache after neck pain; Patients with neck tightness and limited range of motion.Exclusion criteria: History of cervical spine surgery or history of severe cervical spine trauma; Combination of severe osteoporosis, bone tumor, and bone tuberculosis; Combination of cardiovascular, cerebrovascular, digestive, hematologic and other serious medical diseases; Combined with mental diseases, such as claustrophobia and mental retardation; Pregnant or lactating women; People with language comprehension and expression disorders; Contraindications to magnetic resonance, such as metal foreign bodies in the body; and pacemaker implantation.Dropout Criteria: Cases that have been enrolled but have not completed the clinical program should be considered to have dropped out in the following cases: The patient withdraws from the study on his/her own; Subjects with poor compliance cannot come for treatment as required, and the patient does not cooperate; The treatment is effective during treatment but cannot complete the entire observation program.; The treatment is effective during treatment, but the patient cannot complete the entire observation program; The subject does not withdraw from the study but no longer accepts the treatment and loses the visit; In the course of the study, other diseases occur, and the treatment is stopped for more than one week in the middle of the study.